BioLineRx (BLRX) Interest Coverage Ratio (2011 - 2025)
BioLineRx's (BLRX) quarterly Interest Coverage Ratio came in at 12.09 in Q4 2025, up 1192.89% year-on-year from 0.94 in Q4 2024, and up 66.57% quarter-over-quarter from 7.26 in Q3 2025.
BioLineRx (BLRX) Interest Coverage Ratio (2011 - 2025) Analysis & Trends
BioLineRx's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 12.09 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 1192.89% year-over-year to 12.09 in Q4 2025; TTM through Dec 2025 was 8.04, a 74.84% decrease from a year earlier, with the FY2025 full-year figure at 8.04, up 259.11% from the prior year.
- Interest Coverage Ratio advanced to 12.09 in Q4 2025 per BLRX's latest filing, from 7.26 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 32.68 in Q1 2022 and bottomed at 3.69 in Q4 2021.
- The 5-year median for Interest Coverage Ratio is 7.88 (2023), against an average of 10.65.
- Across the five-year window, Interest Coverage Ratio plunged 77.55% in 2024 and surged 1192.89% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 3.69 in 2021, then gained by 13.17% to 3.21 in 2022, then declined by 9.83% to 3.52 in 2023, then soared by 68.59% to 1.11 in 2024, then jumped by 1192.89% to 12.09 in 2025.
- Per Business Quant, the three latest BLRX Interest Coverage Ratio figures stand at 12.09 (Q4 2025), 7.26 (Q3 2025), and 8.34 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | 12.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.09 |
| Sep 30, 2025 | 7.26 |
| Jun 30, 2025 | 8.34 |
| Mar 31, 2025 | 5.69 |
| Dec 31, 2024 | -1.11 |
| Sep 30, 2024 | 3.32 |
| Jun 30, 2024 | 2.77 |
| Mar 31, 2024 | 5.19 |
| Dec 31, 2023 | -3.52 |
| Sep 30, 2023 | 14.76 |
| Jun 30, 2023 | 7.42 |
| Mar 31, 2023 | 9.55 |
| Dec 31, 2022 | -3.21 |
| Sep 30, 2022 | 26.51 |
| Jun 30, 2022 | 20.06 |
| Mar 31, 2022 | 32.68 |
| Dec 31, 2021 | -3.69 |
| Sep 30, 2021 | 23.82 |
| Jun 30, 2021 | 26.91 |
| Mar 31, 2021 | 18.22 |